An intervention study—The aspirin myocardial infarction study
- 1 January 1977
- Vol. 12 (1) , 59-63
- https://doi.org/10.1007/bf02532973
Abstract
The Aspirin Myocardial Infarction Study is a randomized, double-blind clinical trial designed to study the potential value of aspirin in the reduction of mortality in patients who have had a prior myocardial infarction. This trial is based upon several previously published studies which suggest that aspirin may be valuable in prevention of coronary thrombosis. The requirement of 4200 patients dictates that the study must be multicenter, and good design requires that the study be collaborative with central monitoring and an elaborate committee structure to insure uniformity and comparability.Keywords
This publication has 6 references indexed in Scilit:
- Aspirin and coronary heart disease: findings of a prospective study.BMJ, 1975
- Regular Aspirin Intake and Acute Myocardial InfarctionBMJ, 1974
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974
- ACETYLSALICYLIC ACID AND ARTERIOSCLEROTIC THROMBOEMBOLIC DISEASES IN THE AGEDJournal of the American Geriatrics Society, 1971
- Prevention of coronary and cerebral thrombosis.1956
- Experiences with aspirin (Acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis.1953